Platelet BioGenesis requests that their press release NewsItemId: 20190930005207, “Platelet BioGenesis Receives $56 Million Contract from the Biomedical Advanced Research and Development Authority to Develop Human Stem Cell-Derived Platelets as a Medical Countermeasure to Radiological and Nuclear Exposure” issued on September 30th, 2019 be killed.
Oct. 3, 2019 15:41 UTC
--(BUSINESS WIRE)-- Platelet BioGenesis requests that their press release NewsItemId: 20190930005207, “Platelet BioGenesis Receives $56 Million Contract from the Biomedical Advanced Research and Development Authority (BARDA) to Develop Human Stem Cell-Derived Platelets as a Medical Countermeasure to Radiological and Nuclear Exposure” issued on September 30th, 2019 be killed.
The release was issued in error by Platelet BioGenesis.
A replacement release will be issued at a later date.
Contacts
Sarah Karr
978-518-4817
PlateletBiogenesis@matternow.com
Source:
View this news release online at:
http://www.businesswire.com/news/home/20190930005207/en
